Company Performance: Earnings reports, revenue growth, and profitability directly impact investor confidence and the stock price.

Industry Trends: The overall performance and outlook of the pharmaceutical industry influence investor sentiment towards pharmaceutical companies like Bayer.

Regulatory Environment: Changes in pharmaceutical regulations, drug approvals, and patent laws can significantly affect the stock's valuation.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and GDP growth influence overall market sentiment and investment decisions.

Investor Sentiment: Market perception, news coverage, and investor confidence play a crucial role in short-term price fluctuations.

Competition: The competitive landscape within the pharmaceutical industry, including new drug launches and market share dynamics, impacts Bayer's performance and stock price.

Global Events: Geopolitical events, trade policies, and global health crises can create volatility and affect international companies like Bayer.

Currency Exchange Rates: Fluctuations in the exchange rate between the Euro and other currencies impact Bayer's earnings, as it operates globally.

Dividends: Changes to dividend payments can influence investor demand and the stock price.

Management Decisions: Strategic decisions made by Bayer's management, such as acquisitions, divestitures, and research & development investments, impact investor confidence.

Research and Development: Success in drug development, positive clinical trial results and new product pipelines often drive the stock price higher.